Sahir joined SignalFire in 2024 as a Principal focused on early-stage Health and PharmaTech investments. Prior to SignalFire, Sahir was the first commercial hire and Vice President of Business Development at Iterative Health, a company using artificial intelligence to accelerate the shift towards precision medicine in gastroenterology. He led commercial go-to-market with biopharma partners and large health systems and co-led fundraising efforts.
Before Iterative Health, Sahir worked at Flatiron Health (acquired by Roche), building research partnerships with biopharma to speed drug development using real-world evidence. He began his career at J.P. Morgan, focused on biotech / healthtech M&A and equity capital markets advisory. Sahir graduated with an MBA from Harvard Business School, an MPP from the Harvard Kennedy School of Government, and a BA in Economics from Columbia University.
Outside work, Sahir can be found skiing, cycling, or hiking with his Australian Shepherd, Cooper. He enjoys traveling to new places and finding the best slice of pizza in each city.
Stage focus
Seed
Series A & B
Sector Focus
Health & PharmaTech